Updates

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: October 09, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Sub: Update on Rights Issue - Final Reminder cum Forfeiture Notice This is to inform you that the Rights Issue Committee of the Company, by way of a circular resolution passed today, i.e. October 09, 2026, has approved the issuance of a fresh Final Reminder-cum-Forfeiture Notice to the holders of partly paid-up Rights Equity Shares who have not paid the outstanding First Call Money and/or Second and Final Call Money. The Company is in the process of finalizing the notice and will separately intimate the Stock Exchanges upon its dispatch. Kindly take the above information on record. Yours faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer ICSI Membership No. A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033